Correlation Between Ambu AS and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Ambu AS and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ambu AS and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ambu AS and Genmab AS, you can compare the effects of market volatilities on Ambu AS and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ambu AS with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ambu AS and Genmab AS.
Diversification Opportunities for Ambu AS and Genmab AS
Poor diversification
The 3 months correlation between Ambu and Genmab is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Ambu AS and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Ambu AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ambu AS are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Ambu AS i.e., Ambu AS and Genmab AS go up and down completely randomly.
Pair Corralation between Ambu AS and Genmab AS
Assuming the 90 days trading horizon Ambu AS is expected to under-perform the Genmab AS. In addition to that, Ambu AS is 1.58 times more volatile than Genmab AS. It trades about -0.19 of its total potential returns per unit of risk. Genmab AS is currently generating about -0.06 per unit of volatility. If you would invest 155,550 in Genmab AS on August 31, 2024 and sell it today you would lose (4,450) from holding Genmab AS or give up 2.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Ambu AS vs. Genmab AS
Performance |
Timeline |
Ambu AS |
Genmab AS |
Ambu AS and Genmab AS Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ambu AS and Genmab AS
The main advantage of trading using opposite Ambu AS and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ambu AS position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.Ambu AS vs. Bavarian Nordic | Ambu AS vs. Genmab AS | Ambu AS vs. GN Store Nord | Ambu AS vs. DSV Panalpina AS |
Genmab AS vs. Ambu AS | Genmab AS vs. DSV Panalpina AS | Genmab AS vs. Bavarian Nordic | Genmab AS vs. GN Store Nord |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |